203 related articles for article (PubMed ID: 29620699)
1. Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine.
Hommers L; Scharl M; Hefner G; Hohner M; Fischer M; Pfuhlmann B; Deckert J; Unterecker S
J Clin Psychopharmacol; 2018 Jun; 38(3):188-192. PubMed ID: 29620699
[TBL] [Abstract][Full Text] [Related]
2. A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism.
Riesselman A; Strobl B; Cooley AT; de Leon J
J Clin Psychopharmacol; 2013 Dec; 33(6):812-4. PubMed ID: 24113673
[No Abstract] [Full Text] [Related]
3. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
[TBL] [Abstract][Full Text] [Related]
4. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Valproic Acid on Olanzapine Serum Concentration: A Study Including 2791 Patients Treated With Olanzapine Tablets or Long-Acting Injections.
Tveito M; Smith RL; Høiseth G; Molden E
J Clin Psychopharmacol; 2019; 39(6):561-566. PubMed ID: 31688390
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
[TBL] [Abstract][Full Text] [Related]
8. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.
Diaz FJ; Santoro V; Spina E; Cogollo M; Rivera TE; Botts S; de Leon J
Pharmacopsychiatry; 2008 May; 41(3):81-91. PubMed ID: 18484549
[TBL] [Abstract][Full Text] [Related]
9. Reduction in N-Desmethylclozapine Level Is Determined by Daily Dose But Not Serum Concentration of Valproic Acid-Indications of a Presystemic Interaction Mechanism.
Smith RL; Kyllesø L; Haslemo T; Andreassen OA; Molden E
Ther Drug Monit; 2019 Aug; 41(4):503-508. PubMed ID: 31259880
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
11. Effects of comedication on the serum levels of aripiprazole: evidence from a routine therapeutic drug monitoring service.
Castberg I; Spigset O
Pharmacopsychiatry; 2007 May; 40(3):107-10. PubMed ID: 17541885
[TBL] [Abstract][Full Text] [Related]
12. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
Centorrino F; Baldessarini RJ; Kando J; Frankenburg FR; Volpicelli SA; Puopolo PR; Flood JG
Am J Psychiatry; 1994 Jan; 151(1):123-5. PubMed ID: 8267110
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
15. Can valproic acid be an inducer of clozapine metabolism?
Diaz FJ; Eap CB; Ansermot N; Crettol S; Spina E; de Leon J
Pharmacopsychiatry; 2014 May; 47(3):89-96. PubMed ID: 24764199
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data.
Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740
[TBL] [Abstract][Full Text] [Related]
17. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
19. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
20. A case of pharmacokinetic interference in comedication of clozapine and valproic acid.
Conca A; Beraus W; König P; Waschgler R
Pharmacopsychiatry; 2000 Nov; 33(6):234-5. PubMed ID: 11147932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
